Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sagent Pharmaceuticals launches phase 2 trial to evaluate Camostat Mesilate for Covid-19 treatment
Sagent Pharmaceuticals has launched phase 2 trial to evaluate Camostat Mesilate for Covid-19 treatment. (Credit: mohamed Hassan from Pixabay)
Sagent Pharmaceuticals has launched phase 2 trial to evaluate Camostat Mesilate for Covid-19 treatment. (Credit: mohamed Hassan from Pixabay)